Pathways Cited in the Literature
A list of pathways that have been cited in the literature as figures, data visualizations and top enrichment results.
To date, 583 pathways have been cited a total of 1236 times
- 1q21.1 copy number variation syndrome - WP4905 (Homo sapiens)
-
- 22q11.2 copy number variation syndrome - WP4657 (Homo sapiens)
-
- 3q29 copy number variation syndrome - WP4906 (Homo sapiens)
-
- ACE inhibitor pathway - WP554 (Homo sapiens)
-
- Acetylcholine synthesis - WP175 (Mus musculus)
-
- Activation of NLRP3 inflammasome by SARS-CoV-2 - WP4876 (Homo sapiens)
-
- Acute viral myocarditis - WP4298 (Homo sapiens)
-
- Adipogenesis - WP1331 (Danio rerio)
-
- Adipogenesis - WP155 (Rattus norvegicus)
-
- Adipogenesis - WP236 (Homo sapiens)
-
- Adipogenesis genes - WP447 (Mus musculus)
-
- Aerobic glycolysis - WP4629 (Homo sapiens)
-
- Aflatoxin B1 metabolism - WP1262 (Mus musculus)
-
- AGE/RAGE pathway - WP2324 (Homo sapiens)
-
- Airway smooth muscle cell contraction - WP4962 (Homo sapiens)
-
- Allograft rejection - WP2328 (Homo sapiens)
-
- Alpha 6 beta 4 integrin signaling pathway - WP488 (Mus musculus)
-
- Alpha 6 beta 4 signaling pathway - WP244 (Homo sapiens)
-
- Alzheimer's disease - WP5124 (Homo sapiens)
-
- Alzheimer's disease and miRNA effects - WP2059 (Homo sapiens)
-
- Amino acid metabolism - WP3925 (Homo sapiens)
-
- Amino acid metabolism - WP662 (Mus musculus)
-
- AMP-activated protein kinase signaling - WP1403 (Homo sapiens)
-
- Amyotrophic lateral sclerosis (ALS) - WP2447 (Homo sapiens)
-
- Androgen receptor signaling pathway - WP138 (Homo sapiens)
-
- Angiogenesis - WP1539 (Homo sapiens)
-
- Angiopoietin-like protein 8 regulatory pathway - WP3915 (Homo sapiens)
-
- Angiotensin II signaling (acute) in thick ascending limbs - WP3887 (Rattus norvegicus)
-
- Apoptosis - WP1290 (Rattus norvegicus)
-
- Apoptosis - WP1351 (Danio rerio)
-
- Apoptosis - WP254 (Homo sapiens)
-
- Apoptosis modulation and signaling - WP1772 (Homo sapiens)
-
- Apoptosis modulation by HSP70 - WP384 (Homo sapiens)
-
- Apoptosis modulation by HSP70 - WP487 (Rattus norvegicus)
-
- Apoptosis-related network due to altered Notch3 in ovarian cancer - WP2864 (Homo sapiens)
-
- Arrhythmogenic right ventricular cardiomyopathy - WP2118 (Homo sapiens)
-
- Aryl hydrocarbon receptor pathway - WP2586 (Homo sapiens)
-
- Aryl hydrocarbon receptor pathway - WP2873 (Homo sapiens)
-
- ATM signaling in development and disease - WP3878 (Homo sapiens)
-
- ATM signaling pathway - WP2516 (Homo sapiens)
-
- B cell receptor signaling pathway - WP23 (Homo sapiens)
-
- Base excision repair - WP4752 (Homo sapiens)
-
- Benzene metabolism - WP3891 (Homo sapiens)
-
- Benzo(a)pyrene metabolism - WP696 (Homo sapiens)
-
- Beta-oxidation meta-pathway - WP372 (Rattus norvegicus)
-
- Biochemical pathways: part I - WP3604 (Homo sapiens)
-
- Biogenic amine synthesis - WP154 (Danio rerio)
-
- Biomarkers for pyrimidine metabolism disorders - WP4584 (Homo sapiens)
-
- Biosynthesis of aldosterone and cortisol - WP508 (Rattus norvegicus)
-
- Blood clotting cascade - WP272 (Homo sapiens)
-
- Blood clotting cascade - WP460 (Mus musculus)
-
- BMP signaling in eyelid development - WP3927 (Homo sapiens)
-
- Brain-derived neurotrophic factor (BDNF) signaling pathway - WP2380 (Homo sapiens)
-
- Breast cancer pathway - WP4262 (Homo sapiens)
-
- Caloric restriction and aging - WP4191 (Homo sapiens)
-
- CAMKK2 pathway - WP4874 (Homo sapiens)
-
- Cancer immunotherapy by CTLA4 blockade - WP4582 (Homo sapiens)
-
- Cancer immunotherapy by PD-1 blockade - WP4585 (Homo sapiens)
-
- Cardiac hypertrophic response - WP2795 (Homo sapiens)
-
- Cardiovascular signaling - WP590 (Rattus norvegicus)
-
- Catecholamine synthesis - WP513 (Rattus norvegicus)
-
- CCL18 signaling pathway - WP5097 (Homo sapiens)
-
- Cell cycle - WP179 (Homo sapiens)
-
- Cell cycle and cell division - WP414 (Saccharomyces cerevisiae)
-
- Cell differentiation - expanded index - WP2023 (Homo sapiens)
-
- Cell-type dependent selectivity of CCK2R signaling - WP3679 (Homo sapiens)
-
- Cells and molecules involved in local acute inflammatory response - WP4493 (Homo sapiens)
-
- Cerebral organic acidurias, including diseases - WP4519 (Homo sapiens)
-
- CFTR activity in the plasma membrane - WP1488 (Rattus norvegicus)
-
- Chemokine signaling pathway - WP2292 (Mus musculus)
-
- Chemokine signaling pathway - WP3929 (Homo sapiens)
-
- Cholesterol biosynthesis - WP103 (Mus musculus)
-
- Cholesterol biosynthesis - WP1070 (Bos taurus)
-
- Cholesterol biosynthesis - WP1387 (Danio rerio)
-
- Cholesterol biosynthesis pathway - WP197 (Homo sapiens)
-
- Cholesterol metabolism - WP632 (Rattus norvegicus)
-
- Cholesterol metabolism with Bloch and Kandutsch-Russell pathways - WP4346 (Mus musculus)
-
- Ciliary landscape - WP4352 (Homo sapiens)
-
- Circadian rhythm genes - WP3594 (Homo sapiens)
-
- Codeine and morphine metabolism - WP1604 (Homo sapiens)
-
- Complement activation - WP545 (Homo sapiens)
-
- Complement activation, classical pathway - WP200 (Mus musculus)
-
- Complement and coagulation cascades - WP558 (Homo sapiens)
-
- Complement system - WP2806 (Homo sapiens)
-
- Constitutive androstane receptor pathway - WP2875 (Homo sapiens)
-
- Control of immune tolerance by vasoactive intestinal peptide - WP4484 (Homo sapiens)
-
- Copper homeostasis - WP3286 (Homo sapiens)
-
- Cori cycle - WP1946 (Homo sapiens)
-
- Corticotropin-releasing hormone signaling pathway - WP2355 (Homo sapiens)
-
- COVID-19 adverse outcome pathway - WP4891 (Homo sapiens)
-
- Cytokines and inflammatory response - WP530 (Homo sapiens)
-
- Cytoplasmic ribosomal proteins - WP163 (Mus musculus)
-
- Cytoplasmic ribosomal proteins - WP324 (Danio rerio)
-
- Cytoplasmic ribosomal proteins - WP477 (Homo sapiens)
-
- Cytosine methylation - WP3585 (Homo sapiens)
-
- DDX1 as a regulatory component of the Drosha microprocessor - WP2942 (Homo sapiens)
-
- Deregulation of Rab and Rab effector genes in bladder cancer - WP2291 (Homo sapiens)
-
- Development and heterogeneity of the ILC family - WP3893 (Homo sapiens)
-
- Development of ureteric collection system - WP5053 (Homo sapiens)
-
- Diet-dependent trimethylamine/trimethylamine N-oxide metabolism - WP5219 (Homo sapiens)
-
- Differentiation of white and brown adipocyte - WP2895 (Homo sapiens)
-
- DNA damage response - WP707 (Homo sapiens)
-
- DNA damage response (only ATM dependent) - WP710 (Homo sapiens)
-
- DNA IR-damage and cellular response via ATR - WP4016 (Homo sapiens)
-
- DNA IR-double strand breaks and cellular response via ATM - WP3959 (Homo sapiens)
-
- DNA mismatch repair - WP531 (Homo sapiens)
-
- DNA repair pathways, full network - WP4946 (Homo sapiens)
-
- DNA replication - WP466 (Homo sapiens)
-
- Dopamine metabolism - WP2436 (Homo sapiens)
-
- Dopaminergic neurogenesis - WP1498 (Mus musculus)
-
- Dopaminergic neurogenesis - WP2855 (Homo sapiens)
-
- Drug induction of bile acid pathway - WP2289 (Homo sapiens)
-
- Ebola virus infection in host - WP4217 (Homo sapiens)
-
- Ebstein-Barr virus LMP1 signaling - WP262 (Homo sapiens)
-
- EBV LMP1 signaling - WP1278 (Rattus norvegicus)
-
- Ectoderm differentiation - WP2858 (Homo sapiens)
-
- Effect of progerin on genes involved in progeria - WP4320 (Homo sapiens)
-
- Effects of nitric oxide - WP1995 (Homo sapiens)
-
- EGF/EGFR signaling pathway - WP437 (Homo sapiens)
-
- EGFR tyrosine kinase inhibitor resistance - WP4806 (Homo sapiens)
-
- EGFR1 signaling pathway - WP572 (Mus musculus)
-
- Eicosanoid synthesis - WP167 (Homo sapiens)
-
- Electron transport chain - WP295 (Mus musculus)
-
- Electron transport chain: OXPHOS system in mitochondria - WP111 (Homo sapiens)
-
- Embryonic stem cell pluripotency pathways - WP3931 (Homo sapiens)
-
- Endochondral ossification - WP1270 (Mus musculus)
-
- Endochondral ossification - WP474 (Homo sapiens)
-
- Endochondral ossification with skeletal dysplasias - WP4808 (Homo sapiens)
-
- Endoderm differentiation - WP2853 (Homo sapiens)
-
- Endometrial cancer - WP4155 (Homo sapiens)
-
- Endothelin pathways - WP2197 (Homo sapiens)
-
- Energy metabolism - WP1541 (Homo sapiens)
-
- Envelope proteins and their potential roles in EDMD physiopathology - WP4535 (Homo sapiens)
-
- Epithelial to mesenchymal transition in colorectal cancer - WP4239 (Homo sapiens)
-
- EPO receptor signaling - WP1249 (Mus musculus)
-
- EPO receptor signaling - WP1284 (Rattus norvegicus)
-
- EPO receptor signaling - WP581 (Homo sapiens)
-
- ErbB signaling pathway - WP1261 (Mus musculus)
-
- ErbB signaling pathway - WP1299 (Rattus norvegicus)
-
- ErbB signaling pathway - WP673 (Homo sapiens)
-
- ERK1-ERK2 MAPK cascade - WP402 (Danio rerio)
-
- Estrogen metabolism - WP1302 (Rattus norvegicus)
-
- Estrogen metabolism - WP697 (Homo sapiens)
-
- Estrogen receptor pathway - WP2881 (Homo sapiens)
-
- Estrogen signaling - WP1279 (Rattus norvegicus)
-
- Estrogen signaling pathway - WP712 (Homo sapiens)
-
- Ethanol metabolism production of ROS by CYP2E1 - WP4269 (Homo sapiens)
-
- Eukaryotic transcription initiation - WP1066 (Bos taurus)
-
- Eukaryotic transcription initiation - WP405 (Homo sapiens)
-
- Eukaryotic transcription initiation - WP567 (Mus musculus)
-
- Exercise-induced circadian regulation - WP410 (Homo sapiens)
-
- Exercise-induced circadian regulation - WP544 (Mus musculus)
-
- Extracellular vesicles in the crosstalk of cardiac cells - WP4300 (Homo sapiens)
-
- Familial hyperlipidemia type 2 - WP5109 (Homo sapiens)
-
- Farnesoid X receptor pathway - WP2879 (Homo sapiens)
-
- Fas ligand pathway and stress induction of heat shock proteins - WP314 (Homo sapiens)
-
- Fatty acid beta-oxidation - WP1269 (Mus musculus)
-
- Fatty acid beta-oxidation - WP143 (Homo sapiens)
-
- Fatty acid biosynthesis - WP336 (Mus musculus)
-
- Fatty acid biosynthesis - WP357 (Homo sapiens)
-
- Fatty acid omega-oxidation - WP206 (Homo sapiens)
-
- Fatty acid omega-oxidation - WP33 (Mus musculus)
-
- Fatty acid oxidation - WP2318 (Mus musculus)
-
- FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma - WP4553 (Homo sapiens)
-
- Ferroptosis - WP4313 (Homo sapiens)
-
- FGF signaling pathway - WP152 (Danio rerio)
-
- FGF23 signaling in hypophosphatemic rickets and related disorders - WP4790 (Homo sapiens)
-
- Fibrin complement receptor 3 signaling pathway - WP4136 (Homo sapiens)
-
- Fluoropyrimidine activity - WP1601 (Homo sapiens)
-
- Focal adhesion - WP188 (Rattus norvegicus)
-
- Focal adhesion - WP306 (Homo sapiens)
-
- Focal adhesion - WP85 (Mus musculus)
-
- Focal adhesion: PI3K-Akt-mTOR signaling pathway - WP2841 (Mus musculus)
-
- Focal adhesion: PI3K-Akt-mTOR-signaling pathway - WP3932 (Homo sapiens)
-
- Folate metabolism - WP176 (Homo sapiens)
-
- Folate-alcohol and cancer pathway hypotheses - WP1589 (Homo sapiens)
-
- FOXP3 in COVID-19 - WP5063 (Homo sapiens)
-
- FTO obesity variant mechanism - WP3407 (Homo sapiens)
-
- G protein signaling pathways - WP232 (Mus musculus)
-
- G protein signaling pathways - WP73 (Rattus norvegicus)
-
- G1 to S cell cycle control - WP348 (Rattus norvegicus)
-
- G1 to S cell cycle control - WP413 (Mus musculus)
-
- G1 to S cell cycle control - WP45 (Homo sapiens)
-
- G13 signaling pathway - WP298 (Mus musculus)
-
- G13 signaling pathway - WP520 (Rattus norvegicus)
-
- Galanin receptor pathway - WP4970 (Homo sapiens)
-
- Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases - WP4518 (Homo sapiens)
-
- Ganglio sphingolipid metabolism - WP1423 (Homo sapiens)
-
- Gastric cancer network 1 - WP2361 (Homo sapiens)
-
- Gastric cancer network 2 - WP2363 (Homo sapiens)
-
- Gastrin signaling pathway - WP4659 (Homo sapiens)
-
- GDNF/RET signaling axis - WP4830 (Homo sapiens)
-
- Genes controlling nephrogenesis - WP4823 (Homo sapiens)
-
- Glioblastoma signaling pathways - WP2261 (Homo sapiens)
-
- Glucocorticoid receptor pathway - WP2880 (Homo sapiens)
-
- Glucose-1-phosphate metabolism - WP260 (Saccharomyces cerevisiae)
-
Cites this version
-
- Glucuronidation - WP1276 (Rattus norvegicus)
-
- Glutathione metabolism - WP100 (Homo sapiens)
-
- Glutathione metabolism - WP164 (Mus musculus)
-
- Glutathione metabolism - WP469 (Rattus norvegicus)
-
- Glycerophospholipid biosynthetic pathway - WP2533 (Homo sapiens)
-
- Glycogen catabolism - WP478 (Saccharomyces cerevisiae)
-
- Glycogen metabolism - WP160 (Rattus norvegicus)
-
- Glycogen metabolism - WP317 (Mus musculus)
-
- Glycolysis and gluconeogenesis - WP157 (Mus musculus)
-
- Glycolysis and gluconeogenesis - WP515 (Saccharomyces cerevisiae)
-
- Glycolysis and gluconeogenesis - WP534 (Homo sapiens)
-
- Glycosylation and related congenital defects - WP4521 (Homo sapiens)
-
- Gonadotropin-releasing hormone (GnRH) signaling - WP2901 (Bos taurus)
-
- GPCRs, class A rhodopsin-like - WP455 (Homo sapiens)
-
- GPCRs, class A rhodopsin-like - WP473 (Rattus norvegicus)
-
- GPCRs, class B secretin-like - WP334 (Homo sapiens)
-
- GPCRs, class C metabotropic glutamate, pheromone - WP501 (Homo sapiens)
-
- GPCRs, other - WP117 (Homo sapiens)
-
- GPCRs, other - WP409 (Rattus norvegicus)
-
- GPCRs, other - WP41 (Mus musculus)
-
- GPR40 pathway - WP3958 (Homo sapiens)
-
- Growth hormone (GH) signaling - WP2890 (Bos taurus)
-
- Growth hormone receptor (GHR) signaling - WP2891 (Bos taurus)
-
- Gut-liver indole metabolism - WP3627 (Homo sapiens)
-
- H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity - WP3969 (Homo sapiens)
-
- Hair follicle development: organogenesis - part 2 of 3 - WP2839 (Homo sapiens)
-
- Head and neck squamous cell carcinoma - WP4674 (Homo sapiens)
-
- Hedgehog signaling pathway - WP4249 (Homo sapiens)
-
- Hedgehog signaling pathway - WP574 (Rattus norvegicus)
-
- Hematopoietic stem cell differentiation - WP2849 (Homo sapiens)
-
- Hematopoietic stem cell gene regulation by GABP alpha/beta complex - WP3657 (Homo sapiens)
-
- Heme biosynthesis - WP18 (Mus musculus)
-
- Heme biosynthesis - WP561 (Homo sapiens)
-
- Hepatitis C and hepatocellular carcinoma - WP3646 (Homo sapiens)
-
- Hepatocyte growth factor receptor signaling - WP313 (Homo sapiens)
-
- Hexoses metabolism in proximal tubules - WP3916 (Rattus norvegicus)
-
- Hfe effect on hepcidin production - WP3924 (Homo sapiens)
-
- HIF1A and PPARG regulation of glycolysis - WP2456 (Homo sapiens)
-
- Hippo signaling regulation pathways - WP4540 (Homo sapiens)
-
- Histone modifications - WP2369 (Homo sapiens)
-
- Homologous recombination - WP186 (Homo sapiens)
-
- Host-pathogen interaction of human coronaviruses - interferon induction - WP4880 (Homo sapiens)
-
- Host-pathogen interaction of human coronaviruses - MAPK signaling - WP4877 (Homo sapiens)
-
- Hypertrophy model - WP442 (Rattus norvegicus)
-
- Hypertrophy model - WP516 (Homo sapiens)
-
- Hypertrophy model - WP982 (Bos taurus)
-
- Hypothesized pathways in pathogenesis of cardiovascular disease - WP3668 (Homo sapiens)
-
- Hypothetical network for drug addiction - WP1281 (Rattus norvegicus)
-
- Hypoxia-dependent differentiation of myoblasts - WP5025 (Mus musculus)
-
- Hypoxia-dependent proliferation of myoblasts - WP5024 (Mus musculus)
-
- Hypoxia-dependent self-renewal of myoblasts - WP5023 (Mus musculus)
-
- ID signaling pathway - WP53 (Homo sapiens)
-
- IGF-1 signaling - WP2892 (Bos taurus)
-
- IL-1 signaling pathway - WP3271 (Bos taurus)
-
- IL-1 signaling pathway - WP355 (Rattus norvegicus)
-
- IL-10 anti-inflammatory signaling pathway - WP4495 (Homo sapiens)
-
- IL-18 signaling pathway - WP4754 (Homo sapiens)
-
- IL-2 signaling pathway - WP49 (Homo sapiens)
-
- IL-2 signaling pathway - WP569 (Rattus norvegicus)
-
- IL-3 signaling pathway - WP286 (Homo sapiens)
-
- IL-3 signaling pathway - WP319 (Rattus norvegicus)
-
- IL-3 signaling pathway - WP373 (Mus musculus)
-
- IL-4 signaling pathway - WP395 (Homo sapiens)
-
- IL-5 signaling pathway - WP127 (Homo sapiens)
-
- IL-5 signaling pathway - WP44 (Rattus norvegicus)
-
- IL-6 signaling pathway - WP135 (Rattus norvegicus)
-
- IL-6 signaling pathway - WP387 (Mus musculus)
-
- IL-7 signaling pathway - WP205 (Homo sapiens)
-
- IL-7 signaling pathway - WP297 (Mus musculus)
-
- IL-9 signaling pathway - WP10 (Mus musculus)
-
- IL-9 signaling pathway - WP22 (Homo sapiens)
-
- IL-9 signaling pathway - WP8 (Rattus norvegicus)
-
- IL1 and megakaryocytes in obesity - WP2865 (Homo sapiens)
-
- IL6 signaling pathway - WP364 (Homo sapiens)
-
- Imatinib and chronic myeloid leukemia - WP3640 (Homo sapiens)
-
- Immune response to tuberculosis - WP4197 (Homo sapiens)
-
- Inflammatory response pathway - WP40 (Rattus norvegicus)
-
- Inflammatory response pathway - WP453 (Homo sapiens)
-
- Inflammatory response pathway - WP458 (Mus musculus)
-
- Influence of laminopathies on Wnt signaling - WP4844 (Homo sapiens)
-
- Initiation of transcription and translation elongation at the HIV-1 LTR - WP3414 (Homo sapiens)
-
- Insulin signaling - WP439 (Rattus norvegicus)
-
- Insulin signaling - WP481 (Homo sapiens)
-
- Insulin signaling - WP65 (Mus musculus)
-
- Insulin signaling - WP966 (Bos taurus)
-
- Insulin signaling in adipocytes (diabetic condition) - WP3635 (Homo sapiens)
-
- Insulin signaling in adipocytes (normal condition) - WP3634 (Homo sapiens)
-
- Integrated cancer pathway - WP1971 (Homo sapiens)
-
- Integrin-mediated cell adhesion - WP185 (Homo sapiens)
-
- Integrin-mediated cell adhesion - WP6 (Mus musculus)
-
- Integrin-mediated cell adhesion - WP74 (Rattus norvegicus)
-
- Interactions between immune cells and microRNAs in tumor microenvironment - WP4559 (Homo sapiens)
-
- Interferon type I signaling pathways - WP585 (Homo sapiens)
-
- Interleukin-1 induced activation of NF-kB - WP3656 (Homo sapiens)
-
- Interleukin-11 signaling pathway - WP2332 (Homo sapiens)
-
- Irinotecan pathway - WP229 (Homo sapiens)
-
- Iron metabolism in placenta - WP2007 (Homo sapiens)
-
- Kennedy pathway - WP1771 (Mus musculus)
-
- Ketogenesis and ketolysis - WP4742 (Homo sapiens)
-
- Kinin-Kallikrein pathway - WP5089 (Homo sapiens)
-
- Kit receptor signaling pathway - WP147 (Rattus norvegicus)
-
- Kit receptor signaling pathway - WP304 (Homo sapiens)
-
- Kit receptor signaling pathway - WP407 (Mus musculus)
-
- Leptin and adiponectin - WP3934 (Homo sapiens)
-
- Leptin and adiponectin - WP683 (Mus musculus)
-
- Leptin signaling pathway - WP2034 (Homo sapiens)
-
- let-7 inhibition of ES cell reprogramming - WP3299 (Homo sapiens)
-
- Lipid particles composition - WP3601 (Homo sapiens)
-
- Long-day flowering time pathway - WP622 (Arabidopsis thaliana)
-
- Lung fibrosis - WP3624 (Homo sapiens)
-
- Lung fibrosis - WP3632 (Mus musculus)
-
- Macrophage markers - WP4146 (Homo sapiens)
-
- Major receptors targeted by epinephrine and norepinephrine - WP4589 (Homo sapiens)
-
- Male infertility - WP4673 (Homo sapiens)
-
- Mammary gland development pathway - Involution (Stage 4 of 4) - WP2815 (Homo sapiens)
-
- MAPK cascade - WP422 (Homo sapiens)
-
- MAPK signaling pathway - WP358 (Rattus norvegicus)
-
- MAPK signaling pathway - WP382 (Homo sapiens)
-
- Mapk signaling pathway - WP493 (Mus musculus)
-
- MAPK signaling pathway - WP510 (Saccharomyces cerevisiae)
-
- Matrix metalloproteinases - WP129 (Homo sapiens)
-
- Matrix metalloproteinases - WP441 (Mus musculus)
-
- Mechanisms associated with pluripotency - WP1763 (Mus musculus)
-
- MECP2 and associated Rett syndrome - WP3584 (Homo sapiens)
-
- Melatonin metabolism and effects - WP3298 (Homo sapiens)
-
- Mesodermal commitment pathway - WP2857 (Homo sapiens)
-
- Metabolic pathway of LDL, HDL and TG, including diseases - WP4522 (Homo sapiens)
-
- Metabolic reprogramming in colon cancer - WP4290 (Homo sapiens)
-
- Metapathway biotransformation - WP1251 (Mus musculus)
-
- Metapathway biotransformation - WP1286 (Rattus norvegicus)
-
- Metapathway biotransformation Phase I and II - WP702 (Homo sapiens)
-
- Metastatic brain tumor - WP2249 (Homo sapiens)
-
- Methionine de novo and salvage pathway - WP3580 (Homo sapiens)
-
- Methylation - WP1247 (Mus musculus)
-
- Mevalonate pathway - WP3963 (Homo sapiens)
-
- MFAP5-mediated ovarian cancer cell motility and invasiveness - WP3301 (Homo sapiens)
-
- Microglia pathogen phagocytosis pathway - WP3626 (Mus musculus)
-
- Microglia pathogen phagocytosis pathway - WP3937 (Homo sapiens)
-
- MicroRNAs in cardiomyocyte hypertrophy - WP1544 (Homo sapiens)
-
- MicroRNAs in cardiomyocyte hypertrophy - WP1560 (Mus musculus)
-
- Microtubule cytoskeleton regulation - WP2038 (Homo sapiens)
-
- mir-124 predicted interactions with cell cycle and differentiation - WP3595 (Homo sapiens)
-
- miR-509-3p alteration of YAP1/ECM axis - WP3967 (Homo sapiens)
-
- miR-517 relationship with ARCN1 and USP1 - WP3596 (Homo sapiens)
-
- miRNA regulation of DNA damage response - WP1530 (Homo sapiens)
-
- miRNA role in immune response in sepsis - WP4329 (Homo sapiens)
-
- miRNA targets in ECM and membrane receptors - WP2911 (Homo sapiens)
-
- miRNAs involved in DNA damage response - WP1545 (Homo sapiens)
-
- Mitochondrial complex I assembly model OXPHOS system - WP4324 (Homo sapiens)
-
- Mitochondrial complex III assembly - WP4921 (Homo sapiens)
-
- Mitochondrial complex IV assembly - WP4922 (Homo sapiens)
-
- Mitochondrial long chain fatty acid beta-oxidation - WP401 (Mus musculus)
-
- Monoamine GPCRs - WP1389 (Danio rerio)
-
- Monoamine GPCRs - WP276 (Rattus norvegicus)
-
- Monoamine GPCRs - WP58 (Homo sapiens)
-
- Monoamine transport - WP727 (Homo sapiens)
-
- mRNA processing - WP310 (Mus musculus)
-
- mRNA processing - WP411 (Homo sapiens)
-
- mRNA processing - WP529 (Rattus norvegicus)
-
- MYD88 distinct input-output pathway - WP3877 (Homo sapiens)
-
- Myometrial relaxation and contraction pathways - WP140 (Rattus norvegicus)
-
- Myometrial relaxation and contraction pathways - WP289 (Homo sapiens)
-
- NAD biosynthesis II (from tryptophan) - WP2485 (Homo sapiens)
-
- NAD metabolism, sirtuins and aging - WP3630 (Homo sapiens)
-
- NAD+ biosynthetic pathways - WP3645 (Homo sapiens)
-
- NAD+ metabolism - WP3644 (Homo sapiens)
-
- Nanomaterial-induced inflammasome activation - WP3890 (Homo sapiens)
-
- Nanoparticle triggered autophagic cell death - WP2509 (Homo sapiens)
-
- Nanoparticle triggered regulated necrosis - WP2513 (Homo sapiens)
-
- Neovascularization processes - WP4331 (Homo sapiens)
-
- Nephrogenesis - WP5052 (Homo sapiens)
-
- Netrin-UNC5B signaling pathway - WP4747 (Homo sapiens)
-
- Network map of SARS-CoV-2 signaling pathway - WP5115 (Homo sapiens)
-
- Neural crest cell migration during development - WP4564 (Homo sapiens)
-
- Neural crest cell migration in cancer - WP4565 (Homo sapiens)
-
- Neural crest differentiation - WP2064 (Homo sapiens)
-
- Neuroinflammation - WP4919 (Homo sapiens)
-
- Nicotine effect on dopaminergic neurons - WP1602 (Homo sapiens)
-
- NO/cGMP/PKG mediated neuroprotection - WP4008 (Homo sapiens)
-
- Nod-like receptor (NLR) signaling pathway - WP1294 (Rattus norvegicus)
-
- Nodal signaling pathway - WP341 (Danio rerio)
-
- Non-genomic actions of 1,25 dihydroxyvitamin D3 - WP4341 (Homo sapiens)
-
- Non-homologous end joining - WP438 (Homo sapiens)
-
- Non-small cell lung cancer - WP4255 (Homo sapiens)
-
- Nonalcoholic fatty liver disease - WP4396 (Homo sapiens)
-
- Notch signaling - WP268 (Homo sapiens)
-
- Notch signaling pathway - WP29 (Mus musculus)
-
- Notch signaling pathway - WP517 (Rattus norvegicus)
-
- Notch signaling pathway - WP61 (Homo sapiens)
-
- Novel intracellular components of RIG-I-like receptor pathway - WP3865 (Homo sapiens)
-
- NRF2 pathway - WP2884 (Homo sapiens)
-
- NRF2-ARE regulation - WP4357 (Homo sapiens)
-
- nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell - WP5027 (Homo sapiens)
-
- Nuclear factor, erythroid-derived 2, like 2 signaling pathway - WP2376 (Rattus norvegicus)
-
- Nuclear Receptors - WP509 (Mus musculus)
-
- Nuclear receptors in lipid metabolism and toxicity - WP299 (Homo sapiens)
-
- Nuclear receptors in lipid metabolism and toxicity - WP431 (Mus musculus)
-
- Nuclear receptors meta-pathway - WP2882 (Homo sapiens)
-
- Nucleotide excision repair - WP4753 (Homo sapiens)
-
- Nucleotide-binding oligomerization domain (NOD) pathway - WP1433 (Homo sapiens)
-
- Oncostatin M signaling pathway - WP2374 (Homo sapiens)
-
- One-carbon metabolism - WP241 (Homo sapiens)
-
- One-carbon metabolism - WP435 (Mus musculus)
-
- Orexin receptor pathway - WP5094 (Homo sapiens)
-
- Osteoblast signaling - WP322 (Homo sapiens)
-
- Osteoclast signaling - WP12 (Homo sapiens)
-
- Osteopontin signaling - WP1434 (Homo sapiens)
-
- OSX and miRNAs in tooth development - WP3971 (Homo sapiens)
-
- Ovarian infertility - WP34 (Homo sapiens)
-
- Overview of interferons-mediated signaling pathway - WP4558 (Homo sapiens)
-
- Overview of proinflammatory and profibrotic mediators - WP5095 (Homo sapiens)
-
- Oxidation by cytochrome P450 - WP1274 (Mus musculus)
-
- Oxidation by cytochrome P450 - WP43 (Homo sapiens)
-
- Oxidative damage response - WP3941 (Homo sapiens)
-
- Oxidative phosphorylation - WP1248 (Mus musculus)
-
- Oxidative phosphorylation - WP1283 (Rattus norvegicus)
-
- Oxidative phosphorylation - WP623 (Homo sapiens)
-
- Oxidative stress and redox pathway - WP4466 (Mus musculus)
-
- Oxidative stress response - WP408 (Homo sapiens)
-
- Oxytocin signaling - WP2889 (Homo sapiens)
-
- p38 Mapk signaling pathway - WP294 (Rattus norvegicus)
-
- p38 MAPK signaling pathway - WP400 (Homo sapiens)
-
- p53 pathway - WP655 (Rattus norvegicus)
-
- p53 signal pathway - WP656 (Rattus norvegicus)
-
- p53 signaling - WP2902 (Mus musculus)
-
- Pancreatic adenocarcinoma pathway - WP4263 (Homo sapiens)
-
- Parkin-ubiquitin proteasomal system pathway - WP2359 (Homo sapiens)
-
- Parkinson's disease pathway - WP2371 (Homo sapiens)
-
- Pathogenesis of SARS-CoV-2 mediated by nsp9-nsp10 complex - WP4884 (Homo sapiens)
-
- Pathways affected in adenoid cystic carcinoma - WP3651 (Homo sapiens)
-
- Pathways of nucleic acid metabolism and innate immune sensing - WP4705 (Homo sapiens)
-
- PDGF pathway - WP2526 (Homo sapiens)
-
- PDGFR-beta pathway - WP3972 (Homo sapiens)
-
- Pentose phosphate metabolism - WP134 (Homo sapiens)
-
- Peptide GPCRs - WP131 (Rattus norvegicus)
-
- Peptide GPCRs - WP24 (Homo sapiens)
-
- Photodynamic therapy-induced AP-1 survival signaling - WP3611 (Homo sapiens)
-
- Photodynamic therapy-induced HIF-1 survival signaling - WP3614 (Homo sapiens)
-
- Photodynamic therapy-induced NF-kB survival signaling - WP3617 (Homo sapiens)
-
- Physiological and pathological hypertrophy of the heart - WP1528 (Homo sapiens)
-
- PI3K-Akt signaling pathway - WP4172 (Homo sapiens)
-
- PI3K-AKT-mTOR signaling pathway and therapeutic opportunities in prostate cancer - WP3844 (Homo sapiens)
-
- PI3K/AKT/mTOR - vitamin D3 signaling - WP4141 (Homo sapiens)
-
- PKC-gamma calcium signaling pathway in ataxia - WP4760 (Homo sapiens)
-
- Platelet-mediated interactions with vascular and circulating cells - WP4462 (Homo sapiens)
-
- Pleural mesothelioma - WP5087 (Homo sapiens)
-
- Pluripotent stem cell differentiation pathway - WP2848 (Homo sapiens)
-
- Polar auxin transport - WP2940 (Oryza sativa)
-
- Polyol pathway - WP690 (Homo sapiens)
-
- PPAR signaling pathway - WP2316 (Mus musculus)
-
- PPAR signaling pathway - WP3942 (Homo sapiens)
-
- PPAR-alpha pathway - WP2878 (Homo sapiens)
-
- Prader-Willi and Angelman syndrome - WP3998 (Homo sapiens)
-
- Pregnane X receptor pathway - WP2876 (Homo sapiens)
-
- Primary focal segmental glomerulosclerosis (FSGS) - WP2572 (Homo sapiens)
-
- Prion disease pathway - WP3995 (Homo sapiens)
-
- Prolactin signaling pathway - WP2037 (Homo sapiens)
-
- Prostaglandin signaling - WP5088 (Homo sapiens)
-
- Prostaglandin synthesis and regulation - WP303 (Rattus norvegicus)
-
- Prostaglandin synthesis and regulation - WP374 (Mus musculus)
-
- Prostaglandin synthesis and regulation - WP98 (Homo sapiens)
-
- Proteasome degradation - WP183 (Homo sapiens)
-
- Proteasome degradation - WP302 (Rattus norvegicus)
-
- Proteasome degradation - WP519 (Mus musculus)
-
- Proximal tubule transporters - WP3881 (Rattus norvegicus)
-
- Pyrimidine metabolism - WP4022 (Homo sapiens)
-
- Pyrimidine metabolism and related diseases - WP4225 (Homo sapiens)
-
- RAC1/PAK1/p38/MMP2 pathway - WP3303 (Homo sapiens)
-
- RalA downstream regulated genes - WP2290 (Homo sapiens)
-
- RANKL/RANK signaling pathway - WP2018 (Homo sapiens)
-
- Ras signaling - WP4223 (Homo sapiens)
-
- Regulation of actin cytoskeleton - WP351 (Rattus norvegicus)
-
- Regulation of actin cytoskeleton - WP51 (Homo sapiens)
-
- Regulation of actin cytoskeleton - WP523 (Mus musculus)
-
- Regulation of apoptosis by parathyroid hormone-related protein - WP3872 (Homo sapiens)
-
- Regulation of sister chromatid separation at the metaphase-anaphase transition - WP4240 (Homo sapiens)
-
- Regulation of Wnt / B-catenin signaling by small molecule compounds - WP3664 (Homo sapiens)
-
- Regulatory circuits of the STAT3 signaling pathway - WP4538 (Homo sapiens)
-
- Relationship between glutathione and NADPH - WP2562 (Rattus norvegicus)
-
- Renin-angiotensin system - WP376 (Rattus norvegicus)
-
- Resistin as a regulator of inflammation - WP4481 (Homo sapiens)
-
- Retinoblastoma gene in cancer - WP2446 (Homo sapiens)
-
- Retinol metabolism - WP1259 (Mus musculus)
-
- Rett syndrome - WP4312 (Homo sapiens)
-
- Robo4 and VEGF signaling pathways crosstalk - WP3943 (Homo sapiens)
-
- S1P receptor signal transduction - WP1312 (Rattus norvegicus)
-
- S1P receptor signal transduction - WP26 (Homo sapiens)
-
- SARS coronavirus and innate immunity - WP4912 (Homo sapiens)
-
- SARS-CoV-2 altering angiogenesis via NRP1 - WP5065 (Homo sapiens)
-
- SARS-CoV-2 and COVID-19 pathway - WP4846 (Homo sapiens)
-
- SARS-CoV-2 innate immunity evasion and cell-specific immune response - WP5039 (Homo sapiens)
-
- Seed development - WP2279 (Arabidopsis thaliana)
-
- Seed development - WP2199 (Oryza sativa)
-
- Selective expression of chemokine receptors during T-cell polarization - WP4494 (Homo sapiens)
-
- Selenium micronutrient network - WP15 (Homo sapiens)
-
- Sex determination - WP291 (Caenorhabditis elegans)
-
- SIDS susceptibility pathways - WP1266 (Mus musculus)
-
- Signal transduction of S1P receptor - WP57 (Mus musculus)
-
- Signal transduction through IL1R - WP4496 (Homo sapiens)
-
- Small cell lung cancer - WP4658 (Homo sapiens)
-
- Small ligand GPCRs - WP161 (Rattus norvegicus)
-
- Somatroph axis (GH) and its relationship to dietary restriction and aging - WP4186 (Homo sapiens)
-
- Sphingolipid metabolism overview - WP4725 (Homo sapiens)
-
- Sphingolipid metabolism: integrated pathway - WP4726 (Homo sapiens)
-
- Sphingolipid pathway - WP1422 (Homo sapiens)
-
- Spinal cord injury - WP2431 (Homo sapiens)
-
- Spinal cord injury - WP2433 (Rattus norvegicus)
-
- Splicing factor NOVA regulated synaptic proteins - WP1983 (Mus musculus)
-
- SREBF and miR33 in cholesterol and lipid homeostasis - WP2011 (Homo sapiens)
-
- SREBF and miR33 in cholesterol and lipid homeostasis - WP3137 (Bos taurus)
-
- SREBP signaling - WP3194 (Bos taurus)
-
- Statin inhibition of cholesterol production - WP430 (Homo sapiens)
-
- Statin pathway - WP1 (Mus musculus)
-
- Statin pathway - WP1041 (Bos taurus)
-
- Statin pathway - WP145 (Rattus norvegicus)
-
- Steroid biosynthesis - WP55 (Mus musculus)
-
- Steroid biosynthesis - WP66 (Rattus norvegicus)
-
- Sterol regulatory element-binding proteins (SREBP) signaling - WP1982 (Homo sapiens)
-
- Striated muscle contraction - WP316 (Rattus norvegicus)
-
- Striated muscle contraction pathway - WP383 (Homo sapiens)
-
- Sudden infant death syndrome (SIDS) susceptibility pathways - WP706 (Homo sapiens)
-
- Sulindac metabolic pathway - WP2542 (Homo sapiens)
-
- Synaptic signaling pathways associated with autism spectrum disorder - WP4539 (Homo sapiens)
-
- Synaptic vesicle pathway - WP2267 (Homo sapiens)
-
- Synthesis and degradation of ketone bodies - WP349 (Rattus norvegicus)
-
- Synthesis and degradation of ketone bodies - WP543 (Mus musculus)
-
- T cell receptor and co-stimulatory signaling - WP2583 (Homo sapiens)
-
- T-cell antigen receptor (TCR) pathway during Staphylococcus aureus infection - WP3863 (Homo sapiens)
-
- T-cell receptor signaling pathway - WP69 (Homo sapiens)
-
- Tamoxifen metabolism - WP691 (Homo sapiens)
-
- Target of rapamycin signaling - WP1471 (Homo sapiens)
-
- TCA cycle - WP434 (Mus musculus)
-
- TCA cycle (aka Krebs or citric acid cycle) - WP78 (Homo sapiens)
-
- TCA cycle and deficiency of pyruvate dehydrogenase complex (PDHc) - WP2453 (Homo sapiens)
-
- TGF-beta receptor signaling - WP560 (Homo sapiens)
-
- TGF-beta signaling pathway - WP113 (Mus musculus)
-
- TGF-beta signaling pathway - WP366 (Homo sapiens)
-
- Thiamine metabolic pathways - WP4297 (Homo sapiens)
-
- Thick ascending limb transporters - WP3882 (Rattus norvegicus)
-
- Thymic stromal lymphopoietin (TSLP) signaling pathway - WP2203 (Homo sapiens)
-
- Thyroid stimulating hormone (TSH) signaling pathway - WP2032 (Homo sapiens)
-
- TNF-alpha NF-kB signaling pathway - WP457 (Rattus norvegicus)
-
- TNF-alpha signaling pathway - WP231 (Homo sapiens)
-
- TNF-related weak inducer of apoptosis (TWEAK) signaling pathway - WP2036 (Homo sapiens)
-
- Toll, IMD, JAK/STAT pathways for immune response to pathogens - WP3830 (Drosophila melanogaster)
-
- Toll-like receptor signaling - WP88 (Mus musculus)
-
- Toll-like receptor signaling pathway - WP1309 (Rattus norvegicus)
-
- Toll-like receptor signaling pathway - WP1384 (Danio rerio)
-
- Toll-like receptor signaling pathway - WP75 (Homo sapiens)
-
- Toll-like receptor signaling related to MyD88 - WP3858 (Homo sapiens)
-
- TP53 network - WP1742 (Homo sapiens)
-
- Transcription factor regulation in adipogenesis - WP3599 (Homo sapiens)
-
- Transcription factors regulate miRNAs related to cardiac hypertrophy - WP1559 (Homo sapiens)
-
- Translation factors - WP107 (Homo sapiens)
-
- Translation factors - WP149 (Rattus norvegicus)
-
- Translation factors - WP307 (Mus musculus)
-
- Tryptophan catabolism leading to NAD+ production - WP4210 (Homo sapiens)
-
- Tryptophan metabolism - WP270 (Rattus norvegicus)
-
- Tryptophan metabolism - WP465 (Homo sapiens)
-
- Tryptophan metabolism - WP79 (Mus musculus)
-
- Type I collagen synthesis in the context of osteogenesis imperfecta - WP4786 (Homo sapiens)
-
- Type I interferon induction and signaling during SARS-CoV-2 infection - WP4868 (Homo sapiens)
-
- Type II diabetes mellitus - WP1584 (Homo sapiens)
-
- Type II interferon signaling - WP619 (Homo sapiens)
-
- Type II interferon signaling (IFNG) - WP1253 (Mus musculus)
-
- Type II interferon signaling (IFNG) - WP1289 (Rattus norvegicus)
-
- Type III interferon signaling - WP2113 (Homo sapiens)
-
- Tyrobp causal network in microglia - WP3625 (Mus musculus)
-
- TYROBP causal network in microglia - WP3945 (Homo sapiens)
-
- Urea cycle and associated pathways - WP4595 (Homo sapiens)
-
- Urea cycle and metabolism of amino groups - WP497 (Homo sapiens)
-
- Valproic acid pathway - WP3871 (Homo sapiens)
-
- VEGFA-VEGFR2 signaling - WP3888 (Homo sapiens)
-
- Vitamin B12 metabolism - WP1533 (Homo sapiens)
-
- Vitamin D metabolism - WP1531 (Homo sapiens)
-
- Vitamin D receptor pathway - WP2877 (Homo sapiens)
-
- White fat cell differentiation - WP4149 (Homo sapiens)
-
- Wnt myofibroblastic activation of hepatic stellate cells - WP3649 (Rattus norvegicus)
-
- Wnt signaling - WP428 (Homo sapiens)
-
- Wnt signaling in kidney disease - WP4150 (Homo sapiens)
-
- Wnt signaling pathway - WP363 (Homo sapiens)
-
- Wnt signaling pathway - WP375 (Rattus norvegicus)
-
- Wnt signaling pathway - WP403 (Mus musculus)
-
- Wnt signaling pathway and pluripotency - WP1288 (Rattus norvegicus)
-
- Wnt signaling pathway and pluripotency - WP399 (Homo sapiens)
-
- Wnt signaling pathway and pluripotency - WP723 (Mus musculus)
-
- Zinc homeostasis - WP3529 (Homo sapiens)
-
